Joseph G Cannon

Title: Joseph G Cannon: Innovator in Pharmaceutical Chemistry

Introduction

Joseph G Cannon is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on developing compounds that have therapeutic applications.

Latest Patents

One of Cannon's latest patents is for S-11-hydroxy-10-methylaporphine and its biologically active salt forms. These compounds serve as 5-HT.sub.1A inhibitors, which can be utilized as antidotes for the effects of cocaine and as appetite suppressants. The chemical formula for S-11 Hydroxy-10-Methylaporphine is represented as: ##STR1##. Another significant patent involves antagonists of organophosphate-induced toxicity, specifically analogs and congeners of 4,4'-bis-[(1,3-dioxan-2-ylmethyl)aminoacetyl]biphenyl Dimethbromide. These compounds have proven effective in counteracting paraoxon-induced toxicity and mitigating physiological responses to certain nerve gases.

Career Highlights

Throughout his career, Joseph G Cannon has worked with esteemed organizations such as the University of Iowa Research Foundation and University Patents, Inc. His innovative research has contributed to advancements in medical science and public health.

Collaborations

Cannon has collaborated with notable colleagues, including John P Long and Ranbir K Bhatnagar. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Joseph G Cannon's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to influence therapeutic practices and improve health outcomes.